These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36693157)

  • 1. Transcription Factors and Cancer: Approaches to Targeting.
    Shiah JV; Johnson DE; Grandis JR
    Cancer J; 2023 Jan-Feb 01; 29(1):38-46. PubMed ID: 36693157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of cellular microRNAs by human oncogenic viruses - Implications for tumorigenesis.
    Santos JMO; Gil da Costa RM; Medeiros R
    Biochim Biophys Acta Gene Regul Mech; 2018 Feb; 1861(2):95-105. PubMed ID: 29378330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The non-enzymatic RAS effector RASSF7 inhibits oncogenic c-Myc function.
    Kumaraswamy A; Mamidi A; Desai P; Sivagnanam A; Perumalsamy LR; Ramakrishnan C; Gromiha M; Rajalingam K; Mahalingam S
    J Biol Chem; 2018 Oct; 293(40):15691-15705. PubMed ID: 30139745
    [No Abstract]   [Full Text] [Related]  

  • 4. ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer.
    Luk IY; Reehorst CM; Mariadason JM
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30200227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting transcription factors for cancer gene therapy.
    Libermann TA; Zerbini LF
    Curr Gene Ther; 2006 Feb; 6(1):17-33. PubMed ID: 16475943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oncogenic role of Yin Yang 1.
    Zhang Q; Stovall DB; Inoue K; Sui G
    Crit Rev Oncog; 2011; 16(3-4):163-97. PubMed ID: 22248053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of Transcription Factor Activity During Formation of Cancer-Associated Fibroblasts.
    Kapusta P; Dulińska-Litewka J; Totoń-Żurańska J; Borys A; Konieczny PS; Wołkow PP; Seweryn MT
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Different regulation systems of cell cycle events (dysregulation of these events in the tumoral cell)].
    Colomb E; Martin PM
    Bull Cancer; 1991 Jan; 78(1):1-21. PubMed ID: 2021683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic K-ras stimulates Wnt signaling in colon cancer through inhibition of GSK-3beta.
    Li J; Mizukami Y; Zhang X; Jo WS; Chung DC
    Gastroenterology; 2005 Jun; 128(7):1907-18. PubMed ID: 15940626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression.
    Kolligs FT; Hu G; Dang CV; Fearon ER
    Mol Cell Biol; 1999 Aug; 19(8):5696-706. PubMed ID: 10409758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gli Transcription Factors Mediate the Oncogenic Transformation of Prostate Basal Cells Induced by a Kras-Androgen Receptor Axis.
    Wu M; Ingram L; Tolosa EJ; Vera RE; Li Q; Kim S; Ma Y; Spyropoulos DD; Beharry Z; Huang J; Fernandez-Zapico ME; Cai H
    J Biol Chem; 2016 Dec; 291(49):25749-25760. PubMed ID: 27760825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular targets of the oncogenic transcription factor jun.
    Hartl M; Bader AG; Bister K
    Curr Cancer Drug Targets; 2003 Feb; 3(1):41-55. PubMed ID: 12570660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Id proteins at the cross-road of development and cancer.
    Lasorella A; Uo T; Iavarone A
    Oncogene; 2001 Dec; 20(58):8326-33. PubMed ID: 11840325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling.
    Woo SY; Kim DH; Jun CB; Kim YM; Haar EV; Lee SI; Hegg JW; Bandhakavi S; Griffin TJ; Kim DH
    J Biol Chem; 2007 Aug; 282(35):25604-12. PubMed ID: 17599906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mir-210: a sensor for hypoxic stress during tumorigenesis.
    Mathew LK; Simon MC
    Mol Cell; 2009 Sep; 35(6):737-8. PubMed ID: 19782023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT proteins: from normal control of cellular events to tumorigenesis.
    Calò V; Migliavacca M; Bazan V; Macaluso M; Buscemi M; Gebbia N; Russo A
    J Cell Physiol; 2003 Nov; 197(2):157-68. PubMed ID: 14502555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic transcription factors: cornerstones of inflammation-linked pancreatic carcinogenesis.
    Baumgart S; Ellenrieder V; Fernandez-Zapico ME
    Gut; 2013 Feb; 62(2):310-6. PubMed ID: 21997559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet.
    Luo Y; Yang Y; Liu M; Wang D; Wang F; Bi Y; Ji J; Li S; Liu Y; Chen R; Huang H; Wang X; Swidnicka-Siergiejko AK; Janowitz T; Beyaz S; Wang G; Xu S; Bialkowska AB; Luo CK; Pin CL; Liang G; Lu X; Wu M; Shroyer KR; Wolff RA; Plunkett W; Ji B; Li Z; Li E; Li X; Yang VW; Logsdon CD; Abbruzzese JL; Lu W
    Gastroenterology; 2019 Nov; 157(5):1413-1428.e11. PubMed ID: 31352001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting transcription factors: promising new strategies for cancer therapy.
    Yeh JE; Toniolo PA; Frank DA
    Curr Opin Oncol; 2013 Nov; 25(6):652-8. PubMed ID: 24048019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs in normal and cancer cells: a new class of gene expression regulators.
    Bagnyukova TV; Pogribny IP; Chekhun VF
    Exp Oncol; 2006 Dec; 28(4):263-9. PubMed ID: 17285108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.